28.05.2024 – 14:05ARTTIC Innovation GmbHcanSERV invites applications for "Revolutionising Cancer Patient Care"canSERV Challenge CallOne documentmore
28.05.2024 – 14:00ARTTIC Innovation GmbH3canSERV invites applications for "Revolutionising Cancer Patient Care"canSERV CallOne documentmore
29.04.2024 – 13:00Gerresheimer AG2Gerresheimer partners with RxCap to offer connected adherence solutionsmore
10.04.2024 – 11:00Dr. Reddy's Laboratories SADr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatmentmore
14.03.2024 – 07:31STADA Arzneimittel AGPress release: STADA continues with double-digit sales and profit growth in 2023One documentmore
28.02.2024 – 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘more
28.02.2024 – 13:00LTS Lohmann Therapie-Systeme AGFirst product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the USmore
28.02.2024 – 11:07Helmholtz Zentrum MünchenRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmore
22.02.2024 – 13:23Helmholtz Zentrum MünchenTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical TrialMore information on the therapeutic vaccine TherVacBmore
26.01.2024 – 13:50Biomay AGBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapymore
24.01.2024 – 11:00SHL MedicalSHL Medical partners with SteriPack Group to set up final assembly servicemore
09.01.2024 – 11:02STADA Arzneimittel AGPress release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partnerOne documentmore
19.12.2023 – 13:00LTS Lohmann Therapie-Systeme AGLTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patchesmore
06.12.2023 – 16:00LTS Lohmann Therapie-Systeme AGLTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patchesmore
23.11.2023 – 20:15Fraunhofer-Institut für Produktionstechnologie IPTPooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systemsPress release and imagesmore
22.11.2023 – 17:08STADA Arzneimittel AGPress release: STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolioOne documentmore
13.11.2023 – 13:38Biomay AGBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Servicesmore
17.10.2023 – 11:00SHL MedicalSHL Medical and Lifecore Biomedical enter co-marketing partnership agreementmore
30.08.2023 – 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsOne documentmore
15.08.2023 – 07:01STADA Arzneimittel AG2Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and SpecialtyOne documentmore
05.07.2023 – 17:15Helmholtz Zentrum MünchenPotentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitorsmore
28.06.2023 – 17:13Helmholtz Zentrum MünchenNew Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Inductionmore
27.06.2023 – 11:23RHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmore
15.06.2023 – 09:36Berlin CuresBerlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of Innovation and Growth / Phase II study for BC 007 in the indication Long COVID to start in Junemore
09.03.2023 – 10:00Medias Klinikum GmbH & Co KGThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remissionmore
06.03.2023 – 09:42STADA Arzneimittel AGPress release: STADA sustains strong momentum with double-digit sales and profit growth in 2022One documentmore
01.03.2023 – 11:06Grünenthal GroupJanneke van der Kamp starts as new Chief Commercial Officer at Grünenthalmore
02.01.2023 – 10:01STADA Arzneimittel AGPress release: STADA appoints Boris Döbler as Chief Financial OfficerOne documentmore
14.10.2022 – 17:26Helmholtz Zentrum MünchenSwitching tracks: Changing the trafficking of the glucagon receptor in the liver regulates its metabolic signalingHelmholtz Munich Newsroommore